Table 3 Postoperative Characteristics
Characteristic | Dexmedetomidine group | Placebo group | P value |
|---|---|---|---|
(n = 80) | (n = 80) | ||
Length of stay in PACU, median (IQR), min | 855 (675, 970) | 923 (730, 1020) | 0.073 |
Medication in PACU, median (IQR), min | |||
 Dexmedetomidine in PACU | 168 (160, 184) | 0 (0, 0) | 0.000 |
 Total Dexmedetomidine on operation day a | 360 (338, 378) | 0 (0, 0) | 0.000 |
 Sufentanil in PACU | 0 (0, 0) | 0 (0, 0) | 0.100 |
 Total sufentanil on operation day a | 30 (25, 40) | 34 (25, 46) | 0.070 |
Time with tracheotomy tube, median (IQR), d | 5(5,6) | 5(5,6) | 0.551 |
Total infusion, mean (SD), ml | |||
 The operation day a | 1848.65 ± 622.996 | 1888.44 ± 690.296 | 0.702 |
 The first day after surgery | 931.69 ± 1108.510 | 989.25 ± 1098.572 | 0.742 |
 The second day after surgery | 861.04 ± 954.420 | 868.41 ± 1162.951 | 0.717 |
NRS for oral and maxillofacial area pain, mean (SD) | |||
 The first day after surgery | 1.30 ± 1.226 | 3.20 ± 1.363 | 0.000 |
 The second day after surgery | 1.49 ± 1.534 | 1.53 ± 1.492 | 0.876 |
 The Third day after surgery | 1.39 ± 1.497 | 1.44 ± 1.231 | 0.818 |
NRS for fibular area pain, mean (SD) | |||
 The first day after surgery | 1.59 ± 1.357 | 3.71 ± 1.070 | 0.000 |
 The second day after surgery | 1.49 ± 1.369 | 1.58 ± 1.367 | 0.686 |
 The third day after surgery | 1.55 ± 1.457 | 1.43 ± 1.261 | 0.563 |
Sleep time, median (IQR), h | |||
 The first day after surgery | 6.0 (5.0, 7.0) | 4.0 (3.3, 5.0) | 0.000 |
 The second day after surgery | 5.0 (4.3, 6.0) | 5.0 (4.0, 6.0) | 0.520 |